Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Rule 2.10 Announcement

22 Jan 2016 16:04

22 January 2016

Amlin plc (the “Company”)

Rule 2.10 Announcement

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the “Code”), the Company confirms that, the following number of Shares were transferred from treasury to satisfy the exercise of awards under the Company’s share option schemes.

3,471 ordinary shares at an exercise price of 311.00 pence per share.

It had 506,177,051 ordinary shares of 28.125 pence each with ISIN number GB00B2988H17 (“Shares”) in issue as at the date of this announcement.

The total number of Shares attracting voting rights in the Company is 503,395,641.

The above figure may be used by shareholders to determine the percentage of issued share capital they hold in the Company and if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

Contact:

Mark Stevens

Company Secretary

Amlin plc

020 7746 1000

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel’s Market Surveillance Unit on +44 (0)20 7638 0129.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160122005727/en/

Copyright Business Wire 2016

Date   Source Headline
22nd Apr 20204:35 pmRNSPrice Monitoring Extension
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
20th Apr 20209:18 amRNSAnnouncement re: Rights Issue
20th Apr 20207:05 amRNSStatement from Executive Chairman, Lawrence Stroll
20th Apr 20207:00 amRNSAnnouncement re: Rights Issue
17th Apr 20202:25 pmRNSHolding(s) in Company
17th Apr 20202:17 pmRNSHolding(s) in Company
17th Apr 20202:14 pmRNSHolding(s) in Company
17th Apr 20202:12 pmRNSHolding(s) in Company
8th Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 202010:00 amRNSHolding(s) in Company
8th Apr 20209:00 amRNSAston Martin announces Interim CFO appointment
3rd Apr 20208:15 amRNSSuccessful private placement of nil paid rights
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:10 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSAdditional Listing
31st Mar 20207:00 amRNSAdditional Listing
30th Mar 20205:21 pmRNSAnnouncement re: Rights Issue
30th Mar 20205:19 pmRNSResult of Meeting
24th Mar 20201:05 pmRNSUpdate on operations and the impact of COVID-19
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20202:40 pmRNSAnnual Financial Report
13th Mar 20204:36 pmRNSAnnouncement re: Rights Issue
12th Mar 20204:45 pmRNSSecond Price Monitoring Extn
12th Mar 20204:40 pmRNSPrice Monitoring Extension
28th Feb 202010:00 amRNSTotal Voting Rights
27th Feb 20202:31 pmRNSPublication of a Prospectus
27th Feb 20207:00 amRNSAnnouncement re: Rights Issue
27th Feb 20207:00 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 202011:49 amRNSHolding(s) in Company
21st Feb 202011:31 amRNSHolding(s) in Company
17th Feb 202011:28 amRNSHolding(s) in Company
17th Feb 202011:26 amRNSHolding(s) in Company
17th Feb 202011:22 amRNSHolding(s) in Company
17th Feb 202011:18 amRNSHolding(s) in Company
14th Feb 20203:26 pmRNSDirector/PDMR Shareholding
11th Feb 20203:12 pmRNSDirector/PDMR Shareholding
11th Feb 20203:11 pmRNSHolding(s) in Company
11th Feb 20203:09 pmRNSHolding(s) in Company
11th Feb 20203:05 pmRNSHolding(s) in Company
10th Feb 20204:07 pmRNSPassing Away of Non-Executive Director
31st Jan 20207:00 amRNSIssue of Equity
30th Jan 202010:52 amRNSTotal Voting Rights
7th Jan 20206:01 pmRNSTrading Statement - Clarification
7th Jan 20207:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.